Aviva
BNTX icon

Aviva’s BioNTech BNTX Stock Holding History

Aviva’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-39,338
Closed -$8.85M – 989
2021
Q2 		$8.85M Sell
39,338
-24,880
-39% -$4.69M 0.04% 427
2021
Q1 		$6.97M Buy
64,218
+54,659
+572% +$5.8M 0.03% 435
2020
Q4 		$852K Sell
9,559
-8,757
-48% -$860K ﹤0.01% 871
2020
Q3 		$1.27M Sell
18,316
-84
-0.5% -$6.03K 0.01% 837
2020
Q2 		$1.23M Buy
+18,400
New +$919K 0.01% 856

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Aviva's BNTX Position: Q3 2021 in Review

Aviva sold out of BioNTech (BNTX) in Q3 2021, closing a stake of 39,338 shares — an estimated $8.85M sold.

Aviva first reported a position in BNTX in Q2 2020 and held it in 5 quarters. The position peaked at $8.85M in Q2 2021. 335 funds tracked by Wall St. Rank hold BNTX as of Q3 2021.

  • Aviva reported no remaining BioNTech position as of Q3 2021 after selling out during the quarter.
  • Aviva sold 39,338 BioNTech shares in Q3 2021, an estimated $8.85M.
  • Aviva first reported a position in BioNTech in Q2 2020 and held it in 5 quarters.
  • Aviva's BioNTech position peaked at $8.85M in Q2 2021.
  • 335 funds tracked by Wall St. Rank held BioNTech as of Q3 2021.

Based on Aviva's 13F filing for Q3 2021, filed 12 Nov 2021.